Skip to main content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 42
Tuesday, February 14, 2017, 11:07 a.m. to 1:06 p.m.
Presiding
Len Webber, Vice-Chair (Conservative)

Expand AllCollapse All
Library of Parliament
• Karin Phillips, Analyst
• Marlisa Tiedemann, Analyst
Development of a National Pharmacare Program
As an individual
• Matthew Brougham
Medicines New Zealand
• Heather Roy, Chair of Board, Head Office
• Graeme Jarvis, General Manager, Headquarter
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Monday, March 7, 2016, the Committee resumed its study of the Development of a National Pharmacare Program.

Matthew Brougham made a statement and answered questions.

Committee Business
The Committee proceeded to the consideration of matters related to Committee business.

The Committee resumed consideration of the motion moved by Gordon Brown on Tuesday, December 13, 2016, which read as follows:

That, pursuant to Standing Order 108(2), the Committee immediately undertake a study on thalidomide that: (a) focuses on the forgotten survivors of thalidomide; and (b) examines the effectiveness of the 2015 Thalidomide Survivors Contribution Program.

Motion

John Oliver moved, — That the debate be now adjourned.

The question was put on the motion and it was agreed to on the following recorded division:

YEAS: Ramez Ayoub, Doug Eyolfson, Darshan Singh Kang, John Oliver, Sonia Sidhu — 5;

NAYS: Colin Carrie, Pierre-Luc Dusseault, Rachael Harder — 3.

At 11:58 a.m., the sitting was suspended.

At 12:00 p.m., the sitting resumed.

Development of a National Pharmacare Program
As an individual
• Matthew Brougham
Medicines New Zealand
• Heather Roy, Chair of Board, Head Office
• Graeme Jarvis, General Manager, Headquarter
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Monday, March 7, 2016, the Committee resumed its study of the Development of a National Pharmacare Program.

Heather Roy and Graeme Jarvis made statements and answered questions.

At 1:06 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee